Risk of Fluctuations in the Value of Held Assets and Impairment
First written in FY2019. 7 of 12 entries say "Materialised", first in FY2019. Latest entry: FY2026.
Bando Chemical Industries moved to the "Worse" side of this theme in 2019, 2 years before the typical company in this theme (2021).
The whole theme swung hardest in 2020: 51 of 96 companies on the "Worse" side.
24 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「For the consolidated fiscal year (1 April 2025 to 31 March 2026): High-performance elastomer products business; Izumi-Sennan, Osaka; property, plant and equipment ¥236 million; intangible assets ¥5 million; total ¥242 million」
The high-performance elastomer products business recorded an impairment loss of ¥242 million, a substantial decrease from the ¥5,942 million impairment loss recorded in the previous fiscal year, and no impairment loss was recognized on Aimedic MMT goodwill. - FY2026-H1MaterialisedAnnual report
「Impairment loss ¥53 ¥64」
An impairment loss of ¥64 million was recorded during the current interim consolidated accounting period, indicating that the decline in the value of held assets and impairment continued to materialize. - FY2025WorsenedAnnual report
「An impairment test was performed on goodwill arising from the acquisition of Aimedic MMT based on the latest business plan, resulting in recognition of an impairment loss of ¥3,406 million.」
In addition to the ¥3,406 million impairment loss on Aimedic MMT goodwill, impairment losses included ¥850 million on tangible and intangible fixed assets associated with the end of production at Bando USA and ¥1,604 million in the high-performance elastomer products business, bringing total impairment losses to ¥5,942 million. - FY2025-H1MaterialisedAnnual report
「Impairment loss − ¥53 million」
An impairment loss of ¥53 million was reported in the statement of cash flows for the current interim consolidated accounting period, confirming that impairment of held assets had actually occurred. - FY2024MaterialisedAnnual report
「An impairment test was performed on certain operating assets in the high-performance elastomer products business after indicators of impairment were identified because of a significant decline in profitability. An impairment loss was recorded because the recoverable amount was below the carrying amount.」
An impairment loss totaling ¥1,427 million was actually incurred on operating assets and other assets in the high-performance elastomer products business. - FY2022WorsenedAnnual report
「An impairment test was performed on goodwill arising from the acquisition of Aimedic MMT based on the latest business plan. Because the recoverable amount was below the carrying amount, an impairment loss of ¥4,022 million was recorded.」
An impairment loss of ¥4,022 million was recorded on Aimedic MMT goodwill, and an additional impairment loss of ¥282 million was recognized on Bando USA's operating assets. - FY2021MaterialisedAnnual report
「The impairment loss recognized during the current consolidated fiscal year related to an asset group not attributable to a reportable segment. An impairment loss was recognized because operating losses continued and the total discounted future cash flows were below the carrying amount.」
An impairment loss of ¥105 million was incurred on an asset group not attributable to a reportable segment as operating losses continued. No impairment loss was recognized on Aimedic MMT goodwill during the fiscal year. - FY2020MaterialisedAnnual report
「The impairment loss recognized during the current consolidated fiscal year arose from goodwill generated by the business combination resulting from the acquisition of Aimedic MMT. An impairment test was performed based on the latest business plan, and an impairment loss was recognized because the total discounted future cash flows were below the carrying amount.」
For goodwill arising from the acquisition of Aimedic MMT, future cash flows were below the carrying amount, and an impairment loss of ¥3,274 million was actually incurred. - FY2019MaterialisedAnnual report
「Such assets may require impairment if a decline in profitability, such as a fall in fair value or a situation in which they fail to generate the expected cash flows, means that recovery of the investment is no longer expected. If impairment is recognized, it may have a significant impact on results.」
The risk of changes in the value of held assets and impairment was newly disclosed. During the same fiscal year, an impairment loss of ¥166 million was recognized on software that became idle because of changes to plans and other factors.